19 results
8-K
EX-10.1
EVLO
Evelo Biosciences, Inc.
12 Jul 23
Evelo Biosciences Closes $25.5 Million Private Placement
7:55am
counsel, a conflict of interest exists between such person and the indemnifying party with respect to such claims (in which case, if the person notifies
PRE 14A
EVLO
Evelo Biosciences, Inc.
18 Apr 23
Preliminary proxy
5:24pm
, following his appointment as Global Head of Global Drug Discovery at AbbVie, Inc. (“AbbVie”), to avoid the potential for a conflict of interest … $120,000. The compensation committee evaluated whether any of the work performed by Pay Governance during 2022 raised any conflict of interest
8-K
EVLO
Evelo Biosciences, Inc.
5 Apr 22
Departure of Directors or Certain Officers
5:22pm
Drug Discovery at AbbVie, Inc. (“AbbVie”), to avoid the potential for a conflict of interest arising from similarities in the Company's and Abbvie’s
8-K
EX-3.1
9pb z0uk1
18 Mar 21
Amendments to Articles of Incorporation or Bylaws
4:45pm
8-K
qnhh58y0
28 Feb 20
Departure of Directors or Certain Officers
4:00pm
8-K
EX-10.2
pkatz850fjf7qjdukxeq
18 Sep 19
Departure of Directors or Certain Officers
4:41pm
8-K
EX-10.1
n4qio549gnxt3a2l2
24 Jul 19
Entry into a Material Definitive Agreement
4:19pm
DEF 14A
kbah4nke6u me0
25 Apr 19
Definitive proxy
5:21pm
10-K
EX-10.12
0c63d448xbmdai cw88q
15 Feb 19
Annual report
4:20pm
8-K
EX-3.2
0dcsfcbuhfip519yt0x
11 May 18
Amendments to Articles of Incorporation or Bylaws
4:16pm
S-8
EX-4.4
oyzs6p8ih3o
10 May 18
Registration of securities for employees
5:15pm
S-1/A
EX-10.6
q6mby3
30 Apr 18
IPO registration (amended)
6:22am
S-1/A
EX-3.4
vdky9g77w02
30 Apr 18
IPO registration (amended)
6:22am
- Prev
- 1
- Next